Biomarkers Europe 2026 has ended. This guide stays up as the record of who was there. See upcoming conferences

Biomarker discovery and translation at Biomarkers Europe 2026

Oct 13–14, 2026 Basel, Switzerland ~1k attendees Website

71 organizations at Biomarkers Europe 2026 present work in biomarker discovery & translation: 44 technology and service providers, 14 drug developers and 13 academic, government and non-profit bodies. Between them they bring 88 presentations to the program. Most represented: Novartis (8 on the program), Labcorp (7 on the program), AstraZeneca (4 on the program). As of Oct 8, 2026.

All 137 organizations at Biomarkers Europe 2026 →

Format
Top represented
Showing 1–10 of 71 organizations
OrganizationBiomarkers Europe 2026 Attendance
Novartis
Basel, Switzerland
Large pharma
Swiss pharmaceutical company with marketed medicines in oncology, immunology, neuroscience and cardiovascular disease.
Talk
Tue Oct 13
9:15am–9:40am
Precision Medicine Beyond the Hype: Delivering Real Clinical Impact
Drug–diagnostic commercialization & access
Panel
Tue Oct 13
12:40pm–1:30pm
Application And Integration Of Proteomic Biomarkers In Precision Medicine
with BioAge Labs, Engitix, Cancer Research UK +2 more
Genomics, proteomics and multi-omicsBiomarker discovery & translation
Talk
Tue Oct 13
2:30pm–2:55pm
Spatial Autoimmunity - Challenges and Opportunities in Salivary Glands
with 10x Genomics
Digital pathology & spatial biomarkers
Talk
Tue Oct 13
2:55pm–3:20pm
Translational Biomarkers For Evaluating Biologic Drug Efficacy
Biomarker discovery & translation
Talk
Tue Oct 13
3:20pm–3:45pm
Leveraging UK Biobank to Derive Proteomic Signatures Representative of Disease Biology of Dermatological Indications
with Olink
Genomics, proteomics and multi-omics
Talk
Wed Oct 14
9:10am–9:35am
Digital Health Technology Adoption In Clinical Development
Multimodal & AI-enabled precision medicineDrug–diagnostic commercialization & access
Panel
Wed Oct 14
1:00pm–1:30pm
Biomarker Strategies In Neurodegenerative Therapeutics
with Lundbeck, Cure Parkinson's, Neuro-Bio +2 more
Biomarker discovery & translation
Panel
Wed Oct 14
3:15pm–4:05pm
AI-Enabled Clinical Trial Innovation - From Biomarker Data To Decision
with Merck Healthcare
Multimodal & AI-enabled precision medicine
Labcorp
Burlington, NC
◆Diamond Sponsor
CROs & central labsDiamond Sponsor
Laboratory services company offering diagnostic testing, central lab and biomarker services for drug trials, and companion diagnostic development.
Talk
Tue Oct 13
9:40am–10:05am
Advancing Precision Oncology with Companion Diagnostics: Accelerating Development with elio™ Tissue Complete CDx
Clinical & companion diagnostic developmentGenomics, proteomics and multi-omics
Talk
Tue Oct 13
3:20pm–3:45pm
An Open Approach To Biomarker Discovery And Companion Diagnostics
with Proscia
Biomarker discovery & translationClinical & companion diagnostic development
Workshop
Wed Oct 14
11:20am–1:20pm
Enabling Global Precision Oncology Through Integrated Testing, Monitoring, and Companion Diagnostic Strategies
Clinical & companion diagnostic development
Talk
Wed Oct 14
2:50pm–3:15pm
From Biomarkers To Biological Signatures: Enabling Precision Prevention And Clinical Trials In Cardiometabolic Disease
Biomarker discovery & translation
AstraZeneca
Cambridge, UK
Large pharma
Global pharmaceutical company developing and marketing medicines in oncology, cardiovascular, renal, respiratory and rare diseases.
Talk
Tue Oct 13
9:15am–9:40am
From Digital Pathology To Precision Medicine: Scaling AI-Driven Image Analysis
Digital pathology & spatial biomarkersMultimodal & AI-enabled precision medicine
Panel
Tue Oct 13
12:40pm–1:30pm
Application And Integration Of Proteomic Biomarkers In Precision Medicine
with BioAge Labs, Novartis, Engitix +2 more
Genomics, proteomics and multi-omicsBiomarker discovery & translation
Panel
Tue Oct 13
12:40pm–1:30pm
Overcoming Challenges In Deploying Foundation Models, LLMs And Agentic AI For Pathology Workflows
with Betsi Cadwaladr University Health Board, Roche
Multimodal & AI-enabled precision medicineDigital pathology & spatial biomarkers
Panel
Tue Oct 13
5:10pm–6:00pm
AI-Powered Precision Medicine
with GSK, Healiva, Roche
Multimodal & AI-enabled precision medicine
Panel
Wed Oct 14
8:05am–8:30am
Bringing Digital & AI Into The Clinic: How To Globalise Computational Pathology
Digital pathology & spatial biomarkersMultimodal & AI-enabled precision medicine
Talk
Wed Oct 14
11:45am–12:10pm
Digital Biomarkers, Cancer Networks And Clinical Action
Multimodal & AI-enabled precision medicine
Panel
Wed Oct 14
1:00pm–1:30pm
Deploying Computational Pathology Across The Pharma Pipeline
with StratifAI, Deciphex, UCB +1 more
Digital pathology & spatial biomarkersMultimodal & AI-enabled precision medicine
Merck Healthcare
Darmstadt, Germany
Large pharma
Healthcare business of Merck KGaA, Darmstadt, developing and marketing medicines in oncology, neurology, immunology and fertility.
Talk
Tue Oct 13
11:50am–12:15pm
Precision Medicine: Drug/CDx Regulatory Strategy In The US And EU
Clinical & companion diagnostic development
Panel
Tue Oct 13
12:40pm–1:30pm
IVDR Regulations & Their Impact
with AbbVie, Roche Diagnostics
Clinical & companion diagnostic development
Talk
Tue Oct 13
2:30pm–2:55pm
Profiling Tumor-Associated Antigens - A Screening Approach Using Spatial Highplex IF
with Bio-Techne Spatial
Digital pathology & spatial biomarkers
Talk
Tue Oct 13
2:55pm–3:20pm
To Multiplex Or Not To Multiplex- The Question In Preclinical Drug Development
Biomarker discovery & translation
Talk
Wed Oct 14
8:40am–9:10am
From Data To Design: AI-Driven Generative Biology And The Future Of Personalized Medicine
Multimodal & AI-enabled precision medicine
Panel
Wed Oct 14
3:15pm–4:05pm
AI-Enabled Clinical Trial Innovation - From Biomarker Data To Decision
with Novartis
Multimodal & AI-enabled precision medicine
Lundbeck
Copenhagen, Denmark
Large pharma
Danish pharmaceutical company focused on brain diseases, with medicines in psychiatry, neurology and migraine.
Talk
Tue Oct 13
8:45am–9:15am
New Frontiers In Precision Medicine – The Neurology Example
Biomarker discovery & translation
Panel
Tue Oct 13
1:05pm–1:30pm
Translating Biomarkers From Discovery To Clinical Use
with Step Pharma, Monte Rosa Therapeutics, Humanitas Research Hospital +2 more
Biomarker discovery & translation
Panel
Wed Oct 14
1:00pm–1:30pm
Biomarker Strategies In Neurodegenerative Therapeutics
with Cure Parkinson's, Neuro-Bio, Novo Nordisk +2 more
Biomarker discovery & translation
Talk
Wed Oct 14
4:05pm–4:30pm
Using Biomarkers To Drive Decision-Making In Neurodegenerative Diseases
Biomarker discovery & translation
Illumina
San Diego, CA
◆Platinum Sponsor
Instruments & reagentsPlatinum Sponsor
Makes DNA and RNA sequencing systems and multiomic tools used for biomarker and drug target discovery.
Talk
Tue Oct 13
9:40am–10:05am
Submission required
Talk
Tue Oct 13
3:20pm–3:45pm
Illumina Presentation
Sanofi
Paris, France
Large pharma
French pharmaceutical company with medicines and vaccines in immunology, rare diseases, neurology and oncology.
Talk
Tue Oct 13
11:50am–12:15pm
Untargeted Biomarker Discovery For Toxicological & Pharmacological Investigations In Pre-Clinical Drug Discovery Programs By Spatial Tissue Mass Spectroscopy Imaging Platform
Biomarker discovery & translationDigital pathology & spatial biomarkers
Talk
Tue Oct 13
12:15pm–12:40pm
Clinical Trial Outcome Prediction Through Systematic Data Enrichment: Integrating Pharmacokinetic And Biomarker Data
Multimodal & AI-enabled precision medicine
Diagenode
Liège, Belgium
◇Bronze Sponsor
CROs & central labsBronze Sponsor
Epigenomics company, part of Hologic, offering methylation profiling and bioinformatics services for biomarker discovery, including liquid biopsy and MRD studies.
Talk
Tue Oct 13
3:45pm–4:10pm
Epigenomics At 360° In Liquid Biopsy​: Approaches And Case Studies For Biomarker Discovery And Drug Development​
Liquid biopsy & MRDGenomics, proteomics and multi-omics
Academic & healthcare
Cancer research institute of Queen Mary University of London working on early detection, tumour biology and clinical trials.
Panel
Tue Oct 13
12:40pm–1:30pm
Navigating The Multi-Omics Investment Landscape: How Investors See The Future Of The Field
with Flanders Investment & Trade, HealthSeed, Quant Biomarkers
Genomics, proteomics and multi-omicsDrug–diagnostic commercialization & access
Talk
Tue Oct 13
2:55pm–3:20pm
A Translational Journey To Pancreatic Cancer Detection
Biomarker discovery & translation
BioAge Labs
Richmond, CA
Biotech
Clinical-stage biotech developing drugs for obesity and metabolic diseases based on the biology of aging.
Panel
Tue Oct 13
12:40pm–1:30pm
Application And Integration Of Proteomic Biomarkers In Precision Medicine
with Novartis, Engitix, Cancer Research UK +2 more
Genomics, proteomics and multi-omicsBiomarker discovery & translation
Talk
Wed Oct 14
11:45am–12:10pm

Explore the full Biomarkers Europe 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Basel. Leave your work email and we’ll be in touch.

Privacy

Download the full Biomarkers Europe 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers in biomarker discovery & translation

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Browse Biomarkers Europe 2026 by

Not affiliated with or endorsed by Biomarkers, CDx & Precision Medicine or its organizers. Submit a correction